Novo Nordisk invests US$ 100 mn to expand its R&D facility in China
12:53 EDT 25 Sep 2012 | PharmaBiz
Novo Nordisk, a global healthcare company with 89 years of innovation and leadership in diabetes care, has reaffirmed its long─term commitment to China by investing an additional 100 million US dollars to expand its state─of─the─art science f..
Original Article: Novo Nordisk invests US$ 100 mn to expand its R&D facility in China
More From BioPortfolio on "Novo Nordisk invests US$ 100 mn to expand its R&D facility in China"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
